🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

😇 Excited for the Pittsburgh Annual Oncology Symposium this week! ✨ Join us for updates on cutting edge cancer research, and network with exceptional speakers & leaders in the field ✨✨ UPMC Physician Resources UPMC Hillman Cancer Center John Rhee Ibrahim Halil SAHIN, MD Dennis Hsu Janie Y. Zhang, MD

Thank you PittDeptofMed! Extremely grateful for this bridge funding and hope to use this spur advances in our lab and contribute to the university and UPMC Hillman Cancer Center's mission!

Single-cell characterization and genetic dissection of antibiotic persister cells. Work led by our brilliant and tenacious Sydney Blattman. Columbia Biological Sciences Columbia Systems Biology Biochemistry & Molecular Biophysics NIAID News nature.com/articles/s4158…

🎊🎊Excited to welcome Sebawe Syaj, MD, very talented, brilliant physician & researcher to our GI Oncology research center UPMC Hillman Cancer Center University of Pittsburgh ✨✨We're thrilled to have him join our dry lab team. Looking for exceptional things ahead! Dennis Hsu Ibrahim Halil SAHIN, MD Janie Y. Zhang, MD

🚀 Countdown begins! Just 2 weeks until Pittsburgh GI Cancer Summit! We’re thrilled to host an elite lineup of accomplished speakers & engaging discussions. Join us as we explore latest breakthroughs in GI oncology! ✨Aatur Singhi, MD PhD Dennis Hsu Ibrahim Halil SAHIN, MD Susannah Ellsworth

It was a phenomenal day 😇✨ Grateful to all speakers, colleagues, friends, mentors, mentees, sponsors & supporters! ✨✨✨ John Rhee Aatur Singhi, MD PhD Smitha Krishnamurthi Krishan Jethwa Haeseong Park Dennis Hsu Janie Y. Zhang, MD Ibrahim Halil SAHIN, MD UPMC Hillman Cancer Center

EXCITED to share my PhD work in Cell. We found that the chance of developing metastasis is partly decided by the DNA we inherited. We identified a germline variant in PCSK9 present in 70% of the white women conferring higher risk of breast cancer metastasis. (1/9)

Really cool story! Congratulations Sohail Tavazoie Wenbin Mei

It's not goodbye, just see you later! Dr. Burns will truly be missed as he begins a new chapter at The Ohio State! Wishing him all the best in his new position. His impact on our program and his patients will never be forgotten.♥️

It’s an honor to be part of the team!

Computational discovery and experimental validation of mammalian gut colonization factors. Work led by our own amazing Menghan Liu in collaboration with Sohail Tavazoie lab at Rockefeller University. Columbia Biological Sciences Columbia Systems Biology Biochemistry & Molecular Biophysics cell.com/cell/fulltext/…

We are so proud of you Dr. Joshi!!! Congrats!

Our hematology-oncology fellows are thrilled to be representing our program at #ASCO25! Excited for all the learning and networking opportunities ahead. The energy is contagious! 🌟 ASCO #Fellowship #MedEd

So proud of our 3rd year fellow, Dr. Singh Meghana Singh, for presenting her Phase II clinical research on the use Zanzalintinib in combination with Durva/Treme for unresectable HCC at #ASCO25 ! 🌟 #Hematology #Oncology #Fellowship

Congratulations to our UPMC Hillman Cancer Center GI oncology chief of service, Anwaar Saeed for presenting a rapid oral abstract at ASCO today, showing promising results for DSP107 in MSS CRC in the third line! University of Pittsburgh ASCO

Congratulations to Frank Sinicrope, MD and senior authors for leading the practice changing ATOMIC trial presented at ASCO today! It was a privilege for us at UPMC Hillman Cancer Center to participate in this trial and bring it to our patients in western PA. University of Pittsburgh

Can’t consider it a successful ASCO meeting without a happy hour / dinner with our phenomenal fellows here at UPMC Hillman Cancer Center UPMC Heme-Onc Fellowship Program University of Pittsburgh

😇 Honored to lead & present topline Ph 2 data for DSP107 +/- Atezolizumab in 3L MSS CRC #ASCO25: 🔹 Median OS: 17 months >> 60% improvement over SOC. 🔹 ~80% with liver metastases—the most challenging subset. 🔜 a randomized Phase 2b trial to advance this promising approach ✨

Today, we celebrate our Hematology-Oncology Fellowship graduates — physicians whose compassion, brilliance, and resilience have shaped lives and advanced hope. Your dedication is an inspiration. The future of medicine is brighter because of you. 🩸🎓💙 #UPMC #Hematology #Oncology

🚨 STELLAR-303 makes history! First-ever Ph3 trial to show OS benefit of IO in MSS CRC 🎯 Years of grit & belief led us here 🥹 Endless thanks to Exelixis⁩ for the trust & Dr. Hecht for leading this global win with me! 🎉 ⁦UPMC Hillman Cancer Center⁩ ir.exelixis.com/news-releases/…